机译:人源化抗CD19嵌合抗原受体T细胞在复发/难治性急性淋巴细胞白血病中持续治疗疗效
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Dept Nephrol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Dept Blood Transfus Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Haematol Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
Army Med Univ Ctr Biol Therapy Southwest Hosp Third Mil Med Univ Chongqing Peoples R China;
机译:人源化抗CD19嵌合抗原受体T细胞在复发/难治性急性淋巴细胞白血病中持续治疗疗效
机译:人源化CD19靶向嵌合抗原受体(CAR)修饰的T细胞在儿童和青壮年复发/难治性急性淋巴细胞白血病中的功效
机译:抗CD19嵌合抗原受体T细胞用于治疗复发或难治性E2A-PBX1阳性急性淋巴细胞白血病:3例报告
机译:用慢病毒载体修饰T淋巴细胞以表达抗CD19嵌合抗原受体(CAR)
机译:复发性急性淋巴细胞白血病中NT5C2突变的机制和治疗靶点
机译:CD19型CD19 CAR T用新的抗CD19嵌合抗原受体构建的CD19 CAR T在复发或难治性急性淋巴细胞白血病中构建的疗效和安全性
机译:HLA匹配和HLA-Haploidentical同种异体CD19定向的嵌合抗原受体T细胞输注是在造血干细胞移植前复发或难治性B细胞急性淋巴细胞白血病的可行性